Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $31.6100 (11.38%) ($30.0700 - $32.6200) on Tue. Nov. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.4% (three month average) | RSI | 66 | Latest Price | $31.6100(11.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.3% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(48%) IWM(47%) IWC(44%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.2% in a week (0% probabilities). VIXM(-31%) UUP(-14%) VXX(-13%) EDOC(-5%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.2% (StdDev 2.4%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $29.16(8.4%) | 10 Day Moving Average | $29.83(5.97%) | 20 Day Moving Average | $29.29(7.92%) | To recent high | 0% | To recent low | 22.9% | Market Cap | $4.32b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |